TAE Life Sciences is developing a next-generation boron neutron capture therapy for cancer. After recently introducing Alphabeam, a compact and affordable accelerator-based neutron system suitable ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback